Email Newsletters

Life Sciences

After two patient deaths, Boston Scientific recalls pacemaker

Boston Scientific, a Marlborough medical device manufacturer, has recalled a subset of its Accolade pacemakers due to battery issues leading to malfunctions, where two patient deaths have been reported. 

WuXi construction resumes at delayed $300M facility as BIOSECURE Act stalls

A pause in construction of the $300-million WuXi Biologics manufacturing facility at The Reactory biotech park in Worcester appears to be over.

Hologic names private equity executive to board of directors

Medical device manufacturer Hologic has expanded its board, electing Martin Madaus as the Marlborough-based firm’s newest member of its board of directors, effective last Friday.

Insulet awarded $450M from federal jury in intellectual property dispute with Korean firm

Insulet, an Acton medical device manufacturer, has been awarded $452 million in total damages by a federal jury.
ADVERTISEMENT

Boston Scientific continues acquisition streak, eyes Newton cancer treatment provider

Boston Scientific is expanding its presence in cancer treatment as the Marlborough-based medical device manufacturer intends to acquire Intera Oncology, a Newton-based medical device company focused on interventional oncology therapy.

German biotech firm opens $90M+ facility in Marlborough

After three years of work and nearly $100 million in investments, Sartorius opened its Center for BioProcess Innovation in Marlborough on Thursday.

Ashland life sciences firm granted $2M from Bill & Melinda Gates Foundation

The Bill & Melinda Gates Foundation, a nonprofit addressing inequities on a global scale, has extended its reach to Central Massachusetts, awarding Ashland-based BioSurfaces a $2.06 million grant.

Boston Scientific completes $3.7B purchase of California bowel dysfunction company

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January. 
ADVERTISEMENT

Framingham-based biopharma company announces merger agreement with San Diego firm

The merger would see the combined company operating under the Cullgen name and headquartered in San Diego.

Compromise state economic development bill sees $500M for life sciences, $400M for climate tech

Top Democrats on Tuesday evening filed a compromise economic development bill months after their deadline-day talks collapsed, packing the measure with state support for the life sciences and climate technology industries, ticket sales regulations, a new live theater tax credit, educator diversity reforms and more.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

December Flash Sale! Get 40% off new subscriptions from now until December 19th!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA